Stroke Trial, Recruiting NCT06905015 Sponsor: Warangkana Lapisatepun Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06905015
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old (any gender)
  • Your overall health has been assessed by a doctor and is considered good enough for surgery (rated as ASA class I, II, or III — confirm with trial site if unsure what this means)
  • You are scheduled for a planned (non-emergency) open liver surgery and have been diagnosed with liver cancer (Hepatocellular Carcinoma), bile duct cancer (Cholangiocarcinoma), cancer that has spread to the liver (liver metastasis), or a non-cancerous liver tumour

Who may not be able to join:

  • You are currently pregnant
  • You have a serious heart condition, such as unstable chest pain, heart failure, a significant irregular heartbeat, severe heart valve disease, or a heart event within the last 6 months
  • You have had a significant stroke or have severely narrowed arteries in the neck within the last 6 months
  • Your kidneys are not working well enough (confirmed by a blood test result — confirm with trial site)
  • Your blood does not clot normally, based on specific blood test results (confirm with trial site)
  • You have donated your own blood ahead of surgery (pre-operative autologous blood donation)
  • Your tumour is larger than 10 cm
  • You have had a previous liver surgery

Note — you may be withdrawn from the trial during surgery if:

  • The tumour cannot be fully removed during the operation
  • Your blood pressure drops dangerously low and cannot be controlled
  • You experience a cardiac arrest during the operation
  • Certain required measurements of blood flow and pressure cannot be reached during the operation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Warangkana Lapisatepun, MD. PhD., Chiang Mai University

Phone: 0910688761

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Warangkana Lapisatepun
Registry
ClinicalTrials.gov
Start date
25 November 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇹🇭 Thailand

Primary endpoints

Intraoperative blood loss during parenchymal transection phase and entire operation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov